Business Wire

Infobip and the MoneyGram Haas F1 Team Join Forces to Redefine F1 Fan Experiences

6.5.2025 12:23:00 CEST | Business Wire | Press Release

Share

Global cloud communications platform Infobip has signed a multi-year partnership with the MoneyGram Haas F1 Team, helping the Team to create deeper connections with fans worldwide. Infobip’s technology will power a new era of digital engagement, delivering real-time, personalized experiences that bring fans closer to the action.

With a shared commitment to engineering excellence and innovation, the partnership brings together two performance-driven teams focused on pushing boundaries, on and off the track. Infobip, America’s leading messaging platform, will help the MoneyGram Haas F1 Team create richer, more interactive fan journeys combining platforms like Rich Communication Services (RCS), WhatsApp, and in-app messaging with the power of agentic AI.

Infobip’s rich messaging channels, such as RCS, are becoming increasingly popular, with demand surging in North America and globally.

These channels are well suited to deliver richer, more interactive experiences across every touchpoint, from marketing to fan engagement and customer support. Ultimately, Infobip’s technology will help the MoneyGram Haas F1 Team to connect with fans in new, personalized ways, driving loyalty on and off track. For example, fans could learn more about their favourite driver through conversational AI, which would answer questions and provide interactions over WhatsApp and other messaging platforms.

Infobip is Croatia’s first unicorn company with revenue exceeding €1.8 billion in 2024. It provides communications tools to some of world's biggest online companies such as Google and Uber, enabling customers to leverage various channels like WhatsApp, RCS and Apple Messages for Business.

It is also heavily involved in the automotive sector, helping manufacturers like Toyota, Nissan, and Mahindra transform the customer experience during the purchasing process using AI.

The partnership with America’s only Formula 1 Team, headquartered in Kannapolis, North Carolina, began at the Miami Grand Prix on 2-4 May and continues throughout the season.

The MoneyGram Haas F1 Team, currently sixth overall in the Constructors’ Championship, returned to the Miami Grand Prix for Round 6 of the 2025 FIA Formula 1 World Championship – hosted at the Miami International Autodrome in Miami, Florida, 2-4 May.

Ayao Komatsu, Team Principal at the MoneyGram Haas F1 Team, said: “As an engineering firm at heart, Infobip understands what it takes to continue to innovate and deliver results week in, week out. Infobip has grown quickly and has become a global leader. Such drive is something we appreciate, given our ambitions as a team with a growing global fanbase.”

Ivan Ostojić, Chief Business Officer at Infobip, said: “From Austin to Miami, Infobip helps brands stay in pole position by providing rich conversational experiences that enhance customer loyalty and drive growth. Our data shows that RCS traffic has grown exponentially over the last two years in North America and globally, and the channel has the potential to be transformational for customers. By supporting the team in using such channels and providing richer and more interactive experiences, we will help bring fans closer to the action.”

About Infobip

Infobip is a global cloud communications platform that enables businesses to build connected experiences across all stages of the customer journey. Accessed through a single platform, Infobip’s omnichannel engagement, identity, user authentication and contact centre solutions help businesses and partners overcome the complexity of consumer communications to grow business and increase loyalty. It offers natively built technology with the capacity to reach over seven billion mobile devices and ‘things’ in 6 continents connected to over 9,700+ connections of which 800+ are direct operator connections. Infobip was established in 2006 and is led by its co-founders, CEO Silvio Kutić, Roberto Kutić and Izabel Jelenić.

About MoneyGram Haas F1 Team:

2025 sees MoneyGram Haas F1 Team celebrate its tenth season in the FIA Formula 1 World Championship. The first American Formula 1 team to compete in the sport since 1986, MoneyGram Haas F1 Team made an immediate impression with a memorable points-scoring debut at the 2016 Australian Grand Prix. Founded by industrialist Gene Haas – owner of Haas Automation, the largest CNC machine tool builder in North America with over 80 outlets globally – MoneyGram Haas F1 Team is headquartered in Kannapolis, North Carolina in the United States with additional operations in Banbury, England and Maranello, Italy. Technical partnerships with Scuderia Ferrari and Toyota GAZOO Racing further underline MoneyGram Haas F1 Team’s commitment to excellence within Formula 1. Domestically Gene Haas remains a stalwart of the American motorsport scene having started his own NASCAR team in 2002. A 2008 partnership with champion driver Tony Stewart led to the renamed Stewart-Haas Racing becoming a powerhouse operation winning two NASCAR Cup titles and two NASCAR Xfinity championships through to the end of the program in 2024. Haas’s personal dedication to NASCAR continues with the creation of Haas Factory Team for 2025 – running in both the Cup and Xfinity series.

Info – www.haasf1team.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250506471332/en/

Contacts

For more information, contact
Marcelo Nahime
Marcelo.Nahime@infobip.com

MoneyGram Haas F1 Team Contacts:
Stuart Morrison – Head of Communications, MoneyGram Haas F1 Team
Email: smorrison@haasf1team.com / Tel: +44 7779 773466
Jessica Borrell – Senior Communications Manager, MoneyGram Haas F1 Team
Email: jborrell@haasf1team.com / Tel: +44 7851 332967

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye